20
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Protease Inhibitors in Plasma and Faecal Extracts from Patients with Active Inflammatory Bowel Disease

, &
Pages 598-604 | Published online: 08 Jul 2009
 

Abstract

The level and functional activity of the major protease inhibitors in plasma and faecal extracts were analysed in 26 consecutive patients admitted during their first attack of acute severe colitis. The patients were retrospectively divided into two groups: one with total colitis and another with distal colitis. The patients with total colitis had a significantly lower alpha2-macroglobulin level in plasma than normal individuals and patients with distal disease, whereas no difference in the levels of alpha1-protease inhibitor, antichymotrypsin, antithrombin III, and alpha2-antiplasmin was noted between the two groups. The protease-inhibiting capacity was saturated, and free proteolytic activity was present in the faecal extracts. In the extracts complex formation was demonstrated between leukocyte proteases and the antiproteases alpha-protease inhibitor and alpha2-macroglobulin. It is concluded that the low plasma level of alpha2-macroglobulin in patients with severe total colitis is mainly due to a consumption caused by complex formation with proteases, as earlier demonstrated in patients with acute pancreatitis and sepsis.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.